Actively Recruiting
Enhancing Attention and Wellbeing Using Digital Therapeutics
Led by University of California, San Francisco · Updated on 2026-02-24
4000
Participants Needed
1
Research Sites
269 weeks
Total Duration
On this page
Sponsors
U
University of California, San Francisco
Lead Sponsor
N
National Institute on Aging (NIA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goals of the proposed research are to first determine the minimal and/or optimal dose of a digital intervention required for cognitive enhancement, and then to examine the impact of several potential moderators of treatment effects (i.e., cognitive decline, AD polygenic hazard score, cardiovascular risk, and race/ethnicity). This knowledge gained from his high-impact study with transform the field of cognitive interventions, paving the way for a precision medicine model for cognitive enhancing interventions that improve quality of life for older adults and individuals with cognitive deficits at risk of developing dementia.
CONDITIONS
Official Title
Enhancing Attention and Wellbeing Using Digital Therapeutics
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 60+ years old (adult)
- English language fluency
- Owning a smartphone or tablet
You will not qualify if you...
- Under 60 years old (minor)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California San Francisco
San Francisco, California, United States, 94158
Actively Recruiting
Research Team
D
David Ziegler, PhD
CONTACT
M
Monique de Villa, MS, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here